Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H S Merki

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Deutsche Medizinische Wochenschrift (1946)|September 16, 1988
[Long-term intragastric pH-metry. Methods and clinical significance]H S Merki
The Netherlands Journal of Medicine|March 1, 1989
Assessment of intragastric acidity in man: modern aspects and reproducibility of intragastric pH monitoringH S Merki
Gastroenterology|January 1, 1994
Do continuous infusions of omeprazole and ranitidine retain their effect with prolonged dosing?H S Merki, C H Wilder-Smith
Journal of Clinical Gastroenterology|January 1, 1989
Safety and efficacy of roxatidine acetate. Evidence from pharmacodynamic and clinical trialsH S Merki, W Bender, R Labs
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1992
Tolerance during dosing with H2-receptor antagonists. An overviewC H Wilder-Smith, H S Merki
Scandinavian Journal of Gastroenterology|May 1, 1991
Is the time of dosing of a potent long-acting H2-receptor antagonist critical? Twenty-four-hour pH measurements with SKF-94482C H Wilder-Smith, H S Merki
Der Internist|July 1, 1991
[Chronobiologic phenomena in gastroenterology]W Inauen, J G Moore, H S Merki
Digestive Diseases and Sciences|December 1, 1991
Tolerance and rebound to H2-receptor antagonists: intragastric acidity in patients with duodenal ulcerC H Wilder-Smith, F Halter, H S Merki
Gastroenterology|September 1, 1993
Diurnal secretory patterns and tolerance during individually titrated infusions of ranitidineH S Merki, F Halter, C H Wilder-Smith
British Journal of Clinical Pharmacology|January 1, 1995
Individual and group dose-responses to intravenous omeprazole in the first 24 h: pH-feedback-controlled and fixed-dose infusionsC H Wilder-Smith, H U Bettschen, H S Merki
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Deutsche Medizinische Wochenschrift (1946)|September 16, 1988
[Long-term intragastric pH-metry. Methods and clinical significance]H S Merki
The Netherlands Journal of Medicine|March 1, 1989
Assessment of intragastric acidity in man: modern aspects and reproducibility of intragastric pH monitoringH S Merki
Gastroenterology|January 1, 1994
Do continuous infusions of omeprazole and ranitidine retain their effect with prolonged dosing?H S Merki, C H Wilder-Smith
Journal of Clinical Gastroenterology|January 1, 1989
Safety and efficacy of roxatidine acetate. Evidence from pharmacodynamic and clinical trialsH S Merki, W Bender, R Labs
Scandinavian Journal of Gastroenterology. Supplement|January 1, 1992
Tolerance during dosing with H2-receptor antagonists. An overviewC H Wilder-Smith, H S Merki
Scandinavian Journal of Gastroenterology|May 1, 1991
Is the time of dosing of a potent long-acting H2-receptor antagonist critical? Twenty-four-hour pH measurements with SKF-94482C H Wilder-Smith, H S Merki
Der Internist|July 1, 1991
[Chronobiologic phenomena in gastroenterology]W Inauen, J G Moore, H S Merki
Digestive Diseases and Sciences|December 1, 1991
Tolerance and rebound to H2-receptor antagonists: intragastric acidity in patients with duodenal ulcerC H Wilder-Smith, F Halter, H S Merki
Gastroenterology|September 1, 1993
Diurnal secretory patterns and tolerance during individually titrated infusions of ranitidineH S Merki, F Halter, C H Wilder-Smith
British Journal of Clinical Pharmacology|January 1, 1995
Individual and group dose-responses to intravenous omeprazole in the first 24 h: pH-feedback-controlled and fixed-dose infusionsC H Wilder-Smith, H U Bettschen, H S Merki
Pageof 4